It has been a rough few days for Clemson coach Dabo Swinney. First, his 19th-ranked Tigers lost to Louisville on Saturday night, then he was told he couldn’t vote Tuesday at his polling place. Swinney ...

Fintel reports that on November 5, 2024, William Blair downgraded their outlook for Marqeta (NasdaqGS:MQ) from Outperform to ...

William Blair analysts on Monday raised their revenue and profit estimates for Nvidia over the next two fiscal years, citing ...

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, announced today the expansion of its Equity Capital Markets ...

Glaukos Corporation's Q3 revenue grew 24% to $96.7 million, beating estimates, with an EPS loss of $(0.28). 2024 sales guidance raised despite anticipated headwinds.

Morgan Stanley's Keith Weiss took an unusual approach to backing away from his bearish stance on Tuesday, as he moved from an underweight call to a "not-rated" position in the wake of earnings.

William Blair analyst Louie DiPalma has maintained their bearish stance on PLTR stock, giving a Sell rating yesterday. Louie DiPalma has given ...

Mikel Arteta said Arsenal have no plans to appeal William Saliba's red card against Bournemouth and insisted his side must blame themselves for the 2-0 loss on the south coast. The 10-player ...

William Blair analyst Dylan Becker maintained a Buy rating on Enfusion (ENFN – Research Report) today. The company’s shares opened today at $9.12. Becker covers the Technology sector, focusing on ...